Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11390921
Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
granted -
US 11390884
Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
granted -
US 11390848
Materials and methods for modifying the activity of T cells
granted -
US 11390683
Anti-mesothelin polypeptides and proteins
granted -
US 11390667
Compositions and methods for the treatment of neuromyelitis optica
granted -
US 11390631
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11389663
Laser assisted wound healing protocol and system
granted -
CA 3207179
METHODES DE TRAITEMENT DE LA MALADIE DE CROHN ET DE LA COLITE ULCEREUSE
granted -
US 11384139
Antibody targeting cell surface deposited complement protein C3d and use thereof
granted -
US 11382890
Prevention of rosacea inflammation
granted -
US 11384154
Targeted chimeric proteins and uses thereof
granted -
US 11384355
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
granted -
US 11385233
Methods of depleting malignant T-cells
granted -
US 11384153
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
granted -
US 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11382922
Aqueous oral pharmaceutical suspension compositions
granted -
US 11382981
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11384350
Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
granted -
US 11384098
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11384076
Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) FLT3 inhibitors
granted -
US 11384065
Heterocyclic compound as CSF-1R inhibitor and use thereof
granted -
US 11384055
Glycolate oxidase inhibitors for the treatment of disease
granted -
US 11384062
Deuterated (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
granted -
US 11382989
Engineered microbial population
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.